The spot corresponding to hypoxanthine phosphoribosyltransferase (HPRT; IMP:pyrophosphate phosphoribosyltransferase, EC 2.4.2.8) has been identified in twodimensional polyacrylamide gels of HeLa cell extracts. This spot is absent in gels of 24 HPRT deficient mutants. A missense mutant displays a new HPRT spot at the same molecular weight but different isoelectric focusing position. Five (3) (4) (5) (6) . In the present work, we demonstrate that HPRT mutants and revertants can be analyzed by two-dimensional polyacrylamide gel electrophoresis of crude cell extracts. In this procedure, proteins are separated in one dimension by isoelectric focusing, and then in a second dimension by sodium dodecyl sulfate/polyacrylamide gel electrophoresis (7).
mutant proteins. These results indicate that in revertant cell lines a previously silent HPRT gene is activated and produces wild-type HPRT, while simultaneously the mutant HPRT gene continues producing the mutant protein.
MATERIALS AND METHODS
Cell Growth Conditions. HeLa cells are grown at 370 in an atmosphere of 5% C02-95% air on plastic petri plates (Falcon, 100 mm style dishes) in DME medium consisting of Dulbecco's modified Eagle's medium (Gibco, 13 .5 g of powdered media per liter) containing 10% calf serum (Irvine Scientific), 22 mM sodium bicarbonate, andl5 mM Hepes (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic buffer) adjusted to pH 7.2. All cell lines discussed in this paper have a generation time of [15] [16] [17] [18] [19] [20] hr and a plating efficiency of 50-70%.
Mutagen Treatment. One million wild-type HeLa cells growing exponentially are placed in plates containing 10 ml of fresh DME medium. The medium is removed after 12-24 hr and replaced with DME medium containing mutagen. The mutagens used are ethyl methanesulfonate at 400, 500, and 600 ,ug/ml and N-methyl, N'-nitro, N-nitrosoguanidine at 4, 5, and 6 ,ug/ml. After 24 hr, the medium containing mutagen is removed, the cells are rinsed with 5 ml of phosphate-buffered saline, and 10 ml of fresh DME medium is added to the plates. The cells are grown in DME medium for [5] [6] [7] [8] [9] [10] days prior to the addition of selective medium to allow time for the residual HPRT concentration in mutants to decrease. During this time, the cells are transferred so that they do not exhaust the medium. The three levels of ethyl methanesulfonate and nitrosoguanidine kill approximately 60%, 90%, and 98% of the cells, respectively.
Mutant Selections. Ten milliliters of selective "TG medium" containing 0.1 mM 6-thioguanine in DME-medium is added to plates containing approximately 4 to 8 X 106 mutagentreated cells. After 3-7 days, the medium and cell debris are removed and fresh TG medium is added. Colonies are observed 14-21 days after addition of TG medium. Colonies are removed with a pasteur pipet and grown in TG medium. Each mutant cell line is recloned by plating the cells at a low density and isolating individual colonies. To avoid duplication of mutants, only one mutant colony is retained from each initial plate of mutagenized cells. Approximately one-half of the mutagentreated plates of cells yield mutant colonies. More than 108 untreated cells were examined, and none gave spontaneous mutant colonies. Twenty-four independent mutants labeled H1 to H24 were analyzed by two-dimensional gel electrophoresis. This paper deals mainly with an apparent missense mutant H23, and revertants from this mutant.
Revertant Selection. HeLa cells lacking HPRT activity are treated with mutagen and grown for 24 hr in DME medium. cell line at each density (20 plates) is switched into 10 ml mutant selection TG medium. On day 10, the medium is replaced with 10 ml of fresh TG medium. On day 14, colonies are counted. The average number and mean deviation of colonies in each plate is presented in Table 1 . Spontaneous mutants of H23R1, H23R3, and H23R4 were cloned and their extracts were ex- amined by two-dimensional polyacrylamide gel electrophoresis. RESULTS The location of HPRT in two-dimensional polyacrylamide gels of crude HeLa cell extracts is indicated by the arrows in the autoradiographs in Figs. IA and 2A. The HPRT spot is also clearly visible in Coomassie brilliant blue stained gels which are not shown. The following evidence demonstrates that the spot is HeLa HPRT: the HPRT spot appears at the same molecular weight (26,000) and isoelectric focusing position (pH 6) as human red blood cell HPRT. Moreover, when purified HPRT from human red blood cells is added to HeLa cell extracts, the major HPRT isozyme from red blood cell, corresponding to the most basic isozyme focusing at pH 6 (11), coincides with the HeLa HPRT spot. We have examined two-dimensional autoradiographs of 24 mutants lacking HPRT activity, and in every one, the HPRT spot is the only spot in this region which is missing. Finally, when extracts of wild-type HeLa cells are passed through a column containing Sepharose-conjugated HPRT antibody, the two-dimensional pattern is identical except that the HPRT spot disappears (Fig. 2B) . No change in pattern is seen if the extract is instead passed through a column of Sepharose-conjugated preimmune antibody ( Fig. 2A) .
We have isolated a potential missense mutant H23 which produces a normal amount of antigenic HPRT protein, but has Proc. Nati. Acad (Fig. 2D) , which indicates that it is an altered form of HPRT. No change in pattern is observed if the extract is instead passed through a column of Sepharose-conjugated preimmune antibody (Fig. 2C) .
The HPRT spots can also be identified in two-dimensional gels of HPRT immunoprecipitated from cell extracts (Fig. 3) . The HPRT region in an autoradiograph of a two-dimensional gel of immunoprecipitated wild-type HeLa extract is shown in Fig. 4A . The major spot in the pattern corresponds in position to the location of the HPRT spot in two-dimensional gels of crude HeLa extracts (see Fig. 1 ). Similarly, the major spot in the pattern from immunoprecipitated H23 extract (Fig. 4B) occurs at the location of the H23 HPRT spot in two-dimensional gels of crude H23 extracts. A two-dimensional gel of a mixture of immunoprecipitated wild-type HeLa and H23 extracts is shown in Fig. 4C .
We have isolated five independent revertants of mutant H23. Two-dimensional gels of immunoprecipitated HPRT from all five revertants give the same pattern which is shown in Fig. 4D (Table 1) . It is unlikely that the mutants arise by a mutation in the activated wild-type gene as the frequency of appearance is too high. Moreover, two-dimensional gels demonstrate that the spontaneous mutants all synthesize only the mutant H23 gene product, whereas one might expect other types of altered proteins from structural gene mutations. Probably, the spontaneous mutants arise from an event which reverses or negates the initial process which activated the gene. Such an event could be the loss of an inducer required for gene or chromosome expression, the activation of a repressor turning off gene or chromosome expression, or the loss of the chromosome (13, 14) containing the activated wild-type gene. Further study of HPRT gene activation may help elucidate general mechanisms of gene regulation.
Other investigators have suggested that a silent HPRT gene may be activated under some conditions (15) (16) (17) (18) . Although Kahan and DeMars (18) suggest activation of HPRT on an inactive X-chromosome, it is usually assumed that the silent gene is synonymous with the normal wild-type gene which has been turned off. Our data indicate that an HPRT gene which is normally off can be activated. This observation should serve as a caveat in the interpretation of apparent HPRT revertants.
